Jonathan Chang

Stock Analyst at Leerink Partners

(0)
# 4944
Out of 5,344 analysts
132
Total ratings
20.63%
Success rate
-28.54%
Average return
25 Stocks
Name Action PT Current % Upside Ratings Updated
GMAB Genmab
Upgrades: Outperform
27
20.82 29.68% 10 Feb 13, 2025
VINC Vincerx Pharma
Maintains: Outperform
80 40
n/a n/a 6 Oct 8, 2024
IMCR Immunocore Hldgs
Initiates Coverage On: Outperform
74
31.14 137.64% 1 Apr 29, 2024
NBTX Nanobiotix
Initiates Coverage On: Outperform
11
3.85 185.71% 1 Dec 8, 2023
NVCR NovoCure
Initiates Coverage On: Outperform
51
18.55 174.93% 1 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
90 75
4.59 1533.99% 12 Jan 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
30 34
8.36 306.7% 9 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
6
n/a n/a 1 Nov 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
14
n/a n/a 1 Nov 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
18 2
n/a n/a 6 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
100 40
n/a n/a 6 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
3 2
n/a n/a 7 Nov 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
48 50
8.07 519.58% 4 Aug 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
31 30
39.75 -24.53% 4 Aug 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 12
1.5 700% 8 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
2 1
n/a n/a 7 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
13 14
0.35 3900% 5 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 26
5.13 406.82% 5 Jun 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
101 95
31.3 203.51% 8 May 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
20 60
n/a n/a 5 May 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
2 3
0.28 971.43% 8 May 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
5 4
n/a n/a 5 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
41 28
5.64 396.45% 3 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
57 53
7.57 600.13% 7 Aug 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
50 0
n/a n/a 2 May 10, 2018